These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users. Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study]. Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P; Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944 [TBL] [Abstract][Full Text] [Related]
5. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs. Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520 [TBL] [Abstract][Full Text] [Related]
6. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease. Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403 [TBL] [Abstract][Full Text] [Related]
8. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Targownik LE; Metge CJ; Leung S; Chateau DG Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634 [TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. Moore RA; Derry S; Phillips CJ; McQuay HJ BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784 [TBL] [Abstract][Full Text] [Related]
10. [Guideline 'NSAID use and the prevention of gastric damage']. Moens HJ; van Croonenborg JJ; Al MJ; van den Bemt PM; Lourens J; Numans ME; Ned Tijdschr Geneeskd; 2004 Mar; 148(13):604-8. PubMed ID: 15083624 [TBL] [Abstract][Full Text] [Related]
11. Use of gastrointestinal preventive therapy among elderly persons receiving antiarthritic agents in Nova Scotia, Canada. Hartnell NR; Flanagan PS; MacKinnon NJ; Bakowsky VS Am J Geriatr Pharmacother; 2004 Sep; 2(3):171-80. PubMed ID: 15561649 [TBL] [Abstract][Full Text] [Related]
12. The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis. Lapane KL; Spooner JJ; Pettitt D Am J Manag Care; 2001 Apr; 7(4):402-8. PubMed ID: 11310194 [TBL] [Abstract][Full Text] [Related]
13. Determination of candidates for adjunctive 'gastroprotective' prostaglandins. Adelizzi RA J Am Osteopath Assoc; 1990 Jul; 90(7):598-601. PubMed ID: 2115860 [TBL] [Abstract][Full Text] [Related]
14. Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs. Chan JK; Sleat G; Sharma S; Phoenix G; Graham A Surgeon; 2010 Aug; 8(4):206-10. PubMed ID: 20569940 [TBL] [Abstract][Full Text] [Related]
15. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591 [TBL] [Abstract][Full Text] [Related]
16. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study. Morini S; Zullo A; Oliveti D; Chiriatti A; Marmo R; Chiuri DA; Marotti G; Morelli L; Hassan C J Clin Gastroenterol; 2011 Oct; 45(9):780-4. PubMed ID: 21918387 [TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors. van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747 [TBL] [Abstract][Full Text] [Related]
19. Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies. Medlock S; Eslami S; Askari M; Taherzadeh Z; Opondo D; de Rooij SE; Abu-Hanna A Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1259-1269.e10. PubMed ID: 23792548 [TBL] [Abstract][Full Text] [Related]
20. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs. Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]